(Q44392671)

2 December 2017

title

Functional effects of antipsychotic drugs: comparing clozapine with haloperidol (English)

1 reference

2 December 2017

Deborah R Medoff

1 reference

2 December 2017

Carol A Tamminga

1 reference

2 December 2017

Adrienne C Lahti

1 reference

2 December 2017

Henry H Holcomb

series ordinal

1 reference

2 December 2017

Martin A Weiler

series ordinal

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

2 December 2017

published in

Biological Psychiatry

1 reference

2 December 2017

1 reference

2 December 2017

1 reference

2 December 2017

page(s)

601-608

1 reference

Receptor activity and turnover of dopamine and noradrenaline after neuroleptics

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

Importance of pharmacologic control in PET studies: effects of thiothixene and haloperidol on cerebral glucose utilization in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: differences between normal controls and schizophrenic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

Radioreceptor binding profile of the atypical antipsychotic olanzapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

Positron emission tomography studies on D2 and 5-HT2 receptor binding in risperidone-treated schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

A PET-study of [ 11 C]FLB 457 binding to extrastriatal D 2 -dopamine receptors in healthy subjects and antipsychotic drug-treated patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

Detecting activations in PET and fMRI: levels of inference and power

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

Multisubject fMRI studies and conjunction analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

Brain activation patterns in schizophrenic and comparison volunteers during a matched-performance auditory recognition task

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

Direct determination of dopamine D4 receptors in normal and schizophrenic postmortem brain tissue: a [3H]NGD-94-1 study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

Immediate effects of risperidone on cortico-striato-thalamic loops and the hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

Effect of Antipsychotics on Regional Cerebral Blood Flow Measured with Positron Emission Tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

PET mapping of extrastriatal D2-like dopamine receptors in the human brain using an anatomic standardization technique and [11C]FLB 457

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

The attention system of the human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

In the rat medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

Blunted change in cerebral glucose utilization after haloperidol treatment in schizophrenic patients with prominent negative symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

A three-dimensional statistical analysis for CBF activation studies in human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901602-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(02)01602-5

1 reference

2 December 2017

1 reference